Establishment and genetic characterization of a novel mixed-phenotype acute leukemia cell line with EP300-ZNF384 fusion

How I treat mixed-phenotype acute leukemia

(2015) O. Wolach et al.   BLOOD

A novel recurrent EP300–ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia

(2015) Y Gocho et al.   LEUKEMIA

Strategies for modern biomarker and drug development in oncology

(2014) Alan D Smith et al.   Journal of Hematology & Oncology

Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia

(2014) Bing Li et al.   Journal of Hematology & Oncology

Frameshift mutations of tumor suppressor gene EP300 in gastric and colorectal cancers with high microsatellite instability

(2013) Min Sung Kim et al.   HUMAN PATHOLOGY

Novel agents and biomarkers for acute lymphoid leukemia

(2013) Yanmin Zhao et al.   Journal of Hematology & Oncology

Biomarkers for determining the prognosis in chronic myelogenous leukemia

(2013) Kendra Sweet et al.   Journal of Hematology & Oncology

Epigenetic changes: a common theme in acute myelogenous leukemogenesis

(2013) Soraya E Gutierrez et al.   Journal of Hematology & Oncology

Bivalent recognition of nucleosomes by the tandem PHD fingers of the CHD4 ATPase is required for CHD4-mediated repression

(2012) C. A. Musselman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Mixed-phenotype acute leukemia: historical overview and a new definition

(2010) O K Weinberg et al.   LEUKEMIA

E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemia

(2008) C-h Zhong et al.   LEUKEMIA